Compare FR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FR | CRL |
|---|---|---|
| Founded | 1993 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.0B |
| IPO Year | 1994 | 2000 |
| Metric | FR | CRL |
|---|---|---|
| Price | $58.22 | $197.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $57.64 | ★ $190.15 |
| AVG Volume (30 Days) | ★ 939.7K | 884.6K |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | $714,032,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $10.87 | N/A |
| Revenue Next Year | $7.46 | $1.66 |
| P/E Ratio | $32.53 | ★ N/A |
| Revenue Growth | ★ 8.93 | N/A |
| 52 Week Low | $40.31 | $91.86 |
| 52 Week High | $59.43 | $199.66 |
| Indicator | FR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 60.59 | 70.71 |
| Support Level | $57.80 | $192.09 |
| Resistance Level | $59.43 | $196.38 |
| Average True Range (ATR) | 1.06 | 5.28 |
| MACD | 0.09 | 2.12 |
| Stochastic Oscillator | 68.79 | 90.36 |
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.